CLINICAL TRIALS PROFILE FOR SEYSARA
✉ Email this page to a colleague
All Clinical Trials for SEYSARA
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT04555525 ↗ | A Pilot Study on the Use of Seysara for Rosacea | Completed | Derm Research, PLLC | Phase 4 | 2019-04-15 | This is a prospective, parallel group, randomized, investigator-blinded pilot study. Approximately 100 subjects will be randomized at a 3:1 ratio to Seysara (sarecycline) at a weight-based dose per label or Centrum Adult Multivitamin to take by mouth daily. The study is comprised of 5 visits: screening, baseline, week 4, week 8, and week 12. Investigators will perform rosacea IGA (Investigator Global Assessment,) inflammatory lesion count, record adverse events and con meds, and ask each subject to complete a DLQI (Dermatology Life Quality Index.) |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for SEYSARA
Condition Name
Clinical Trial Locations for SEYSARA
Trials by Country
Clinical Trial Progress for SEYSARA
Clinical Trial Phase
Clinical Trial Sponsors for SEYSARA
Sponsor Name